Clinical Trial Update: A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing the plan to evaluate the efficacy and safety of SP-624 in adults with major depressive disorder, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SP-624 (SP-624)

Snippet

Sponsor: Sirtsei Pharmaceuticals, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING